Compare Match Group Inc (MTCH) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Repligen Corporation Common Stock — how do they compare? Match Group Inc trades at $42.39 (market cap $9.72B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Match Group Inc and Repligen Corporation Common Stock are close in size by market cap, and Match Group Inc pays a 1.89% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Match Group Inc for 115 Days and Repligen Corporation Common Stock for 0 Days on average.
| MTCH | RGEN | |
|---|---|---|
Market Cap | $9.72B | $11.14B |
Volume | 4,140,020 | 1,259,263 |
Sector | Media | Health |
52-Week High | $44.40 | $194.57 |
52-Week Low | $28.90 | $102.87 |
Typical Hold Time | 115 Days | 0 Days |
Enterprise Value | $12.69B | $11.02B |
Dividend Yield | 1.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $42.40, up 2.12% today, with a bullish technical signal and strong support at $41. The company reported a net income margin of 20.17% for 2025, with Q2 2026 EPS beating expectations. Operating cash flow reached $1.08B in 2025, and a $0.20 dividend is scheduled for October 2026. Recent news highlights product innovation at Tinder and growth at Hinge.
The outlook is positive with a consensus price target of $42.29, though high debt levels and competitive pressures pose risks. Analyst sentiment is bullish with 53% buy ratings. Revenue stability and margin expansion support upside potential, but investors should monitor execution on Tinder's turnaround and debt management.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
